Exagen Inc. to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Exagen Inc. (Nasdaq: XGN), a leading autoimmune testing provider, has announced its participation in three upcoming investor conferences in early 2025:

1. BTIG at Snowbird Conference on February 11, 2025, at the Cliff Lodge in Snowbird, UT, featuring one-on-one investor meetings.

2. TD Cowen's 45th Annual Health Care Conference on March 5, 2025, at the Marriott Copley Place in Boston, MA, where President and CEO John Aballi and CFO Jeff Black will participate in a fireside chat at 1:10 p.m. EST, along with one-on-one investor meetings.

3. 5th Annual KeyBanc Capital Markets Healthcare Forum on March 18, 2025, featuring a virtual fireside chat and one-on-one investor meetings.

Investors can find more information and fireside chat links in the Events section of Exagen's website.

CARLSBAD, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences:

BTIG at Snowbird: MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Management will participate in one-on-one investor meetings on Tuesday, February 11ᵗʰ, 2025, at the Cliff Lodge located in Snowbird, UT.

TD Cowen’s 45ᵗʰ Annual Health Care Conference

John Aballi, President and CEO and Jeff Black, CFO, will participate in a fireside chat at 1:10 p.m. EST on Wednesday, March 5ᵗʰ, 2025, at the Marriott Copley Place in Boston, MA. Management will also participate in one-on-one investor meetings.

5ᵗʰ Annual KeyBanc Capital Markets Healthcare Forum

Management will participate virtually in a fireside chat at a time to be determined and one-on-one investor meetings on Tuesday, March 18ᵗʰ, 2025.

Please check the Events section of the Investors page on Exagen.com for more information and links to the fireside chats.

About Exagen

Exagen Inc. (Nasdaq: XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen’s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company’s flagship product, AVISE^® CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sjögren’s syndrome earlier and with greater accuracy. Exagen’s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.

For more information, please visit Exagen.com or follow @ExagenInc on X (formerly known as Twitter).

Exagen Inc.
Ryan Douglas
IR@exagen.com
760.560.1525

FAQ

What investor conferences will Exagen (XGN) attend in early 2025?

Exagen will attend three conferences: BTIG at Snowbird Conference (Feb 11), TD Cowen's Health Care Conference (March 5), and KeyBanc Capital Markets Healthcare Forum (March 18).

When is Exagen's (XGN) fireside chat at TD Cowen's Healthcare Conference?

Exagen's fireside chat at TD Cowen's Healthcare Conference is scheduled for March 5, 2025, at 1:10 p.m. EST in Boston, MA.

Which Exagen (XGN) executives will present at TD Cowen's Conference?

President and CEO John Aballi and CFO Jeff Black will participate in the fireside chat at TD Cowen's Conference.

Where can investors find links to Exagen's (XGN) conference presentations?

Investors can find links to the fireside chats in the Events section of the Investors page on Exagen.com.

Which of Exagen's (XGN) 2025 investor conferences will be virtual?

The KeyBanc Capital Markets Healthcare Forum on March 18, 2025, will be held virtually.